UPLC-MS/MS法同时检测人血浆中6种抗结核药的浓度
Simultaneous determination of six antituberculosis drugs in human plasma by UPLC-MS/MS
分类号:
出版年·卷·期(页码):2016,36 (2):0-0
DOI:
10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------
目的:建立UPLC-MS/MS法用于人血浆中6种抗结核药的同时检测分析,并应用于肺结核患者血药浓度监测。方法:利用蛋白沉淀法将被分析物与生物基质分离,采用Waters ACQUITY UPLC HSS T3(1.8 μm,2.1 mm×100 mm)色谱柱进行色谱分离,以乙腈-15 mmol·L-1甲酸铵-0.05%甲酸为流动相进行梯度洗脱,流速为0.2 mL·min-1,柱温40℃,进样量5 μL;采用电喷雾离子源正离子模式,多反应监测进行测定。结果:乙胺丁醇、异烟肼、吡嗪酰胺、利福平、利福喷丁、利福布汀质量浓度分别在0.05~5、0.1~10、0.2~20、0.05~10、0.05~10、0.05~5 μg·mL-1范围内线性关系良好,相关系数均大于0.99。除吡嗪酰胺在低浓度点的日间精密度小于15.4%外,其他化合物低、中、高3个浓度的日内和日间精密度RSD均小于15%,准确度为88.1%~109.1%,准确度良好。结论:本法经方法学验证,可同时对6种以上抗结核药物进行检测,一步完成,降低了分析成本,为临床调整用药提供了重要的分析手段。
-----英文摘要:---------------------------------------------------------------------------------------
Objective:To develop an ultra high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for determination of six antituberculosis drugs,and to analyze biological samples from clinical trials.Methods:The analytes were isolated from the biological matrix by protein precipitation.The samples were analyzed with a Waters ACQUITY UPLC HSS T3 column(1.8 μm,2.1 mm×100 mm) and eluted with acetonitrile -15 mmol·L-1 ammonium formate-0.05% formic acid solution as mobile phase in gradient mode at a flow rate of 0.2 mL·min-1.The column temperature was controlled at 40℃ and the injection volume was 5 μL.Electrospray ionization(ESI) source was applied and operated in the positive multiple reaction monitoring (MRM) mode.Results:There were good linear relationship between peak areas and injection quality in the range of 0.05-5,0.1-10,0.2-20,0.05-10,0.05-10 and 0.05-5 μg·mL-1 for ethambutol,isoniazid,pyrazinamide,rifampicin,rifapentine and rifabutine,respectively.The inter day precision of pyrazinamide was 15.4% in low concentration,the intra-day and inter-day precision(RSD) other compounds were all below 15%.The accuracy was 88.1%-109.1%.Conclusion:The established method is proved suitable for the simultaneous determination of ethambutol,isoniazid,pyrazinamide,rifampicin,rifapentine and rifabutine in human plasma from clinical plasma samples.By one step,which will significantly reduce the analysis cost,and provide an analysis means for the clinical medication adjustment.
-----参考文献:---------------------------------------------------------------------------------------
[1] 张小丽,赵怀清,侯艳宁.LC/ESL-MS测定小鼠血浆中异烟肼及其代谢物[J].药物分析杂志,2007,27(12):1880 ZHANG XL,ZHAO HQ,HOU YN.LC/ESL-MS determination of isoniazid and its metabolites in mice plasma[J].Chin J Pharm Anal,2007,27(12):1880
[2] 夏志高.反相高效液相色谱法测定血浆中利福喷丁的浓度[J]. 广州医药,2010,41(2):59 XIA ZG.Determination of rifapentine in human plasma by HPLC with UV detection[J].Guangzhou Med J,2010,41(2):59
[3] 刘晓茜,姚亚敏,马芳,等.LC-MS/MS法测定大鼠血浆中的利福布丁[J].华西药学杂志,2012,27(2):184 LIU XQ,YAO YM,MA F,et al.Determination of rifabutin in rats plasma by LC-MS/MS[J].West China J Pharm Sci,2012,27(2):184
[4] 赵冠人,马俊,冯端浩.高效液相色谱法测定人血浆中异烟肼和吡嗪酰胺的浓度[J].中国药师,2012,15(3):353 ZHAO GR,MA J,FENG DH.Determination of isoniazid and pyraginamide in human plasma by HPLC[J].China Pharm,2012, 15(3):353
[5] ALLANSON AL,COTTON MM,TETTEY JNA,et al.Determination of rifampicin in human plasma and blood spots by high performance liquid chromatography with UV detection:A potential method for therapeutic drug monitoring[J].J Pharm Biomed Anal JPBA,2007,44(4):963
[6] 徐溢,徐平洲,曹强,等.采用甲基丙烯酸丁酯整体微柱芯片系统测定血样中痕量异烟肼[J].分析化学,2008,36(12):1636 XU Y,XU PZ,CAO Q,et al.Detection of isoniaz id in plasma on microchip with butylmethacrylate monolithic column[J].Chin J Anal Chem,2008,36(12):1636
[7] 汤兴球,王伍承.HPLC-ELSD法同时测定烟肼丁醇片中盐酸乙胺丁醇和异烟肼的含量[J].安徽医药,2012,16(5):616 TANG XQ,WANG WC.HPLC-ELSD determination of isoniazid and ethambutoland of isoniazid and ethambutol hydrochloride tablets[J].Anhui Med Pharm J,2012,16(5):616
[8] 朱慧,李芃,陆宇.LC-MS/MS方法同时检测人血浆中异烟肼、乙胺丁醇和吡嗪酰胺的浓度[J].药物分析杂志,2012,32(6):945 ZHU H,LI P,LU Y.LC-MS/MS determination of isoniazid, ethambutoland,pyrazinamide in human plasma[J].Chin J Pharm Anal,2012,32(6):945
欢迎阅读《药物分析杂志》!您是该文第 1287位读者!